Your browser doesn't support javascript.
loading
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A).
Solmi, Marco; Estradé, Andrés; Thompson, Trevor; Agorastos, Agorastos; Radua, Joaquim; Cortese, Samuele; Dragioti, Elena; Leisch, Friedrich; Vancampfort, Davy; Thygesen, Lau Caspar; Aschauer, Harald; Schloegelhofer, Monika; Akimova, Elena; Schneeberger, Andres; Huber, Christian G; Hasler, Gregor; Conus, Philippe; Cuénod, Kim Q Do; von Känel, Roland; Arrondo, Gonzalo; Fusar-Poli, Paolo; Gorwood, Philip; Llorca, Pierre-Michel; Krebs, Marie-Odile; Scanferla, Elisabetta; Kishimoto, Taishiro; Rabbani, Golam; Skonieczna-Zydecka, Karolina; Brambilla, Paolo; Favaro, Angela; Takamiya, Akihiro; Zoccante, Leonardo; Colizzi, Marco; Bourgin, Julie; Kaminski, Karol; Moghadasin, Maryam; Seedat, Soraya; Matthews, Evan; Wells, John; Vassilopoulou, Emilia; Gadelha, Ary; Su, Kuan-Pin; Kwon, Jun Soo; Kim, Minah; Lee, Tae Young; Papsuev, Oleg; Manková, Denisa; Boscutti, Andrea; Gerunda, Cristiano; Saccon, Diego.
Affiliation
  • Solmi M; University of Ottawa, Department of Psychiatry, Ontario, Canada; The Ottawa Hospital, Department of Mental Health, Ontario, Canada; University of Ottawa, Ottawa Hospital Research Institute (OHRI) Clinical Epidemiology Program, Ottawa Ontario; Early Psychosis: Interventions and Clinical-detection (EP
  • Estradé A; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; Universidad Católica, Department of Psychology, Montevideo, Uruguay. Electronic address: andres.est
  • Thompson T; University of Greenwich, School of Human Sciences, London, United Kingdom. Electronic address: T.Thompson@greenwich.ac.uk.
  • Agorastos A; Aristotle University of Thessaloniki, II. Dept. of Psychiatry, Division of Neurosciences, Medical School, Faculty of Health Sciences, Greece. Electronic address: aagorast@auth.gr.
  • Radua J; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Re
  • Cortese S; University of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom. Electronic address: samuele.cortese@soton.ac.uk.
  • Dragioti E; Linköping University, Pain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping, Sweden; University of Ioannina, Research Laboratory Psychology of Patients, Families & Health Professionals, Department of Nursing, School of Health Sciences, Ioannina, Greece.
  • Leisch F; University of Natural Resources and Life Sciences, Wien, Austria. Electronic address: Friedrich.Leisch@boku.ac.at.
  • Vancampfort D; Katholieke Universiteit Leuven (KU Leuven), Department of Rehabilitation Sciences, Leuven, Belgium. Electronic address: davy.vancampfort@kuleuven.be.
  • Thygesen LC; National Institute of Public Health, University of Southern Denmark, Denmark. Electronic address: lct@sdu.dk.
  • Aschauer H; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: harald.aschauer@biopsyc.at.
  • Schloegelhofer M; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: monika.schloegelhofer@biopsyc.at.
  • Akimova E; BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria. Electronic address: elena.akimova@biopsyc.at.
  • Schneeberger A; Psychiatric Services Grisons, Department of Adult Psychiatry, Switzerland. Electronic address: andres.schneeberger@pdgr.ch.
  • Huber CG; University of Basel, Universitäre Psychiatrische Kliniken Basel (UPK), Basel, Switzerland. Electronic address: christian.huber@unibas.ch.
  • Hasler G; University of Fribourg, Fribourg Network of Mental Health (RFSM), Fribourg, Switzerland. Electronic address: gregor.hasler@unifr.ch.
  • Conus P; University of Lausanne, Department of Psychiatry, Lausanne, Switzerland. Electronic address: philippe.conus@chuv.ch.
  • Cuénod KQD; University of Lausanne, Department of Psychiatry, Lausanne, Switzerland. Electronic address: Kim.Do@chuv.ch.
  • von Känel R; University Hospital Zurich, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, Switzerland. Electronic address: roland.vonkaenel@usz.ch.
  • Arrondo G; University of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom; University of Navarra, Mind-Brain Group, Institute for Culture and Society (ICS), Pamplona, Spain. Electronic address: garrondo@unav.es.
  • Fusar-Poli P; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology& Neuroscience, King's College London, London, United Kingdom; OASIS service, South London and Maudsley NHS Foundation Trust, London, United Kingdom; University o
  • Gorwood P; Université de Paris, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France; Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014, Paris, France. Electronic address: p.gorwood@ghu-paris.fr.
  • Llorca PM; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Psychiatrie B, Clermont-Ferrand, France. Electronic address: pmllorca@chu-clermontferrand.fr.
  • Krebs MO; Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014, Paris, France; Université de Paris, PEPIT, GHU Paris Psychiatrie et Neuroscience, Paris, France. Electronic address: MO.KREBS@ghu-paris.fr.
  • Scanferla E; Université de Paris, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France. Electronic address: e.scanferla@ghu-paris.fr.
  • Kishimoto T; Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan. Electronic address: tkishimoto@keio.jp.
  • Rabbani G; The National Foundation of Mental Health of Bangladesh, Bangladesh. Electronic address: rabbanigolam33@gmail.com.
  • Skonieczna-Zydecka K; Pomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland. Electronic address: karzyd@pum.edu.pl.
  • Brambilla P; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, Milan, Italy. Electronic address: paolo.brambilla1@unimi.it.
  • Favaro A; University of Padua, Neurosciences Department, Padua, Italy. Electronic address: angela.favaro@unipd.it.
  • Takamiya A; Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan. Electronic address: akihiro.takamiya@keio.jp.
  • Zoccante L; Integrated University Hospital of Verona, Child and Adolescent Neuropsychiatry Unit, Maternal-Child Integrated Care Department, Verona, Italy. Electronic address: leonardo.zoccante@aovr.veneto.it.
  • Colizzi M; University of Verona, Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy. Electronic address: marco.colizzi@univr.it.
  • Bourgin J; Service de Psychiatrie de l'enfant et de l'adolescent, GHNE, 91440 Bures Sur Yvette, France. Electronic address: j.bourgin@gh-nord-essonne.fr.
  • Kaminski K; Medical University of Bialystok, Department of Population Medicine and Lifestyle Diseases Prevention, Bialystok, Poland. Electronic address: fizklin@gmail.com.
  • Moghadasin M; Kharazmi University, Department of Clinical Psychology, Faculty of Psychology and Education, Tehran, Iran. Electronic address: mmoghadasin@yahoo.com.
  • Seedat S; Stellenbosch University, Department of Psychiatry, Faculty of Medicine and Health Sciences, South Africa. Electronic address: sseedat@sun.ac.za.
  • Matthews E; Waterford Institute of Technology, School of Health Sciences, Waterford, Ireland. Electronic address: ematthews@wit.ie.
  • Wells J; Waterford Institute of Technology, School of Health Sciences, Waterford, Ireland. Electronic address: jswells@wit.ie.
  • Vassilopoulou E; University of Nicosia, Department of Life and Health Sciences, Nicosia, Cyprus. Electronic address: vassilopoulouemilia@gmail.com.
  • Gadelha A; Universidade Federal de São Paulo, Department of Psychiatry, São Paulo, Brazil. Electronic address: aryararipe@gmail.com.
  • Su KP; An-Nan Hospital, China Medical University, Department of Psychiatry, Tainan, Taiwan; Maastricht University, Department of Psychiatry and Neuropsychology, Maastricht, The Netherlands. Electronic address: cobolsu@gmail.com.
  • Kwon JS; Seoul National University College of Medicine, Department of Psychiatry, Seoul, Republic of Korea. Electronic address: kwonjs@snu.ac.kr.
  • Kim M; Seoul National University Hospital, Department of Neuropsychiatry, Seoul, Republic of Korea. Electronic address: verte82@snu.ac.kr.
  • Lee TY; Pusan National University Yangsan Hospital, Department of Psychiatry, Yangsan, Republic of Korea. Electronic address: leetaey@gmail.com.
  • Papsuev O; Moscow Research Institute of Psychiatry, Moscow, Russia. Electronic address: oleg.papsouev@gmail.com.
  • Manková D; National Institute of Mental Health, Klecany, Czech Republic. Electronic address: denisa.mankova@nudz.cz.
  • Boscutti A; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy. Electronic address: a.boscutti@gmail.com.
  • Gerunda C; University of Padua, Neurosciences Department, Padua, Italy. Electronic address: cristiano.gerunda@unipd.it.
  • Saccon D; AULSS4 Veneto Orientale, Addictions Department, Italy. Electronic address: diego.saccon@aulss4.veneto.it.
J Affect Disord ; 299: 367-376, 2022 02 15.
Article in En | MEDLINE | ID: mdl-34606810
BACKGROUND: The COVID-19 pandemic has altered daily routines and family functioning, led to closing schools, and dramatically limited social interactions worldwide. Measuring its impact on mental health of vulnerable children and adolescents is crucial. METHODS: The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT - www.coh-fit.com) is an on-line anonymous survey, available in 30 languages, involving >230 investigators from 49 countries supported by national/international professional associations. COH-FIT has thee waves (until the pandemic is declared over by the WHO, and 6-18 months plus 24-36 months after its end). In addition to adults, COH-FIT also includes adolescents (age 14-17 years), and children (age 6-13 years), recruited via non-probability/snowball and representative sampling and assessed via self-rating and parental rating. Non-modifiable/modifiable risk factors/treatment targets to inform prevention/intervention programs to promote health and prevent mental and physical illness in children and adolescents will be generated by COH-FIT. Co-primary outcomes are changes in well-being (WHO-5) and a composite psychopathology P-Score. Multiple behavioral, family, coping strategy and service utilization factors are also assessed, including functioning and quality of life. RESULTS: Up to June 2021, over 13,000 children and adolescents from 59 countries have participated in the COH-FIT project, with representative samples from eleven countries. LIMITATIONS: Cross-sectional and anonymous design. CONCLUSIONS: Evidence generated by COH-FIT will provide an international estimate of the COVID-19 effect on children's, adolescents' and families', mental and physical health, well-being, functioning and quality of life, informing the formulation of present and future evidence-based interventions and policies to minimize adverse effects of the present and future pandemics on youth.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Affect Disord Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Affect Disord Year: 2022 Type: Article